Comments*

 
  • From the Editors

    Blood pressure variability and cardiovascular outcomes

    By Mark Caulfield, London, and Peter Nilsson, Malmo


    The traditional way to evaluate blood pressure is by office recordings, either supine or sitting, but in more recent years home blood pressure measurements and 24-h ambulatory blood pressure recordings (24-h ABPM) have become more widely used. One newer aspect is to measure arterial stiffness by pulse wave velocity (PWV), as an indication of the target organ damage caused by elevated blood pressure.

  • What's New

    ACC.10: ACCORD AND RISK-FACTOR CONTROL IN TYPE 2 DIABETES

    The results of the ACCORD BP (Action to Control Cardiovascular Risk in Diabetes Blood Pressure) trial were presented in Atlanta at the recent annual scientific meeting of the American College of Cardiology. 

    The goal of the ACCORD BP trial was to evaluate a target systolic blood pressure <120 mm Hg compared with <140 mm Hg among patients with type 2 diabetes.

    Read the Editorial by Prof. Peter M. Nilsson, Co-Editor of the ESH Portal on ACCORD and Risk-Factor Control in Type 2 Diabetes.

    Click here to read more on the ACCORD BP trial. A Slide Presentation (PPT) on "Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial" is also available. 

  • Interactive Poll Question

    ACCORD-BP Study

    Following the recent publication of the ACCORD-BP study (N Engl J Med 2010) we know that there was not a significant difference in the primary outcome for composite cardiovascular endpoint when comparing the systolic blood pressuer goal of less than 120 mmHg versus 140 mmHg. Based on data from trials and your experience, what is your own judgement on the systolic blood pressure goal to be recommended in patients with type 2 diabetes?
    less than 120 mmHg
    less than 130 mmHg
    less than 140 mmHg
      Results